BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20960517)

  • 1. GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expression.
    Ko KH; Holmes T; Palladinetti P; Song E; Nordon R; O'Brien TA; Dolnikov A
    Stem Cells; 2011 Jan; 29(1):108-18. PubMed ID: 20960517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSK-3β inhibition promotes early engraftment of ex vivo-expanded haematopoietic stem cells.
    Dolnikov A; Xu N; Shen S; Song E; Holmes T; Klamer G; O'Brien TA
    Cell Prolif; 2014 Apr; 47(2):113-23. PubMed ID: 24517125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitor of glycogen synthase kinase 3β 6-Bromoindirubin-3-oxime inhibits hematopoietic regeneration in stem cell recipient mice.
    Shen S; Xu N; Klamer G; Ko KH; Khoo M; Ma D; Moore J; O'Brien TA; Dolnikov A
    Stem Cells Dev; 2015 Mar; 24(6):724-36. PubMed ID: 25329250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growth.
    Holmes T; O'Brien TA; Knight R; Lindeman R; Shen S; Song E; Symonds G; Dolnikov A
    Stem Cells; 2008 May; 26(5):1288-97. PubMed ID: 18323411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3β inhibition preserves naive T cell phenotype in bone marrow reconstituted mice.
    Shen S; Klamer G; Xu N; O'Brien TA; Dolnikov A
    Exp Hematol; 2013 Dec; 41(12):1016-27.e1. PubMed ID: 24018603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a GSK-3 inhibitor in culture of human cord blood primitive hematopoietic cells.
    Jiang J; Zhao M; Zhang A; Yu M; Lin X; Wu M; Wang X; Lu H; Zhu S; Yu Y; Mao Z; Han W
    Biomed Pharmacother; 2010 Sep; 64(7):482-6. PubMed ID: 20359857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells promote efficient ex vivo expansion of cord blood-derived hematopoietic stem/progenitor cells.
    Qu Q; Liu L; Chen G; Xu Y; Wu X; Wu D
    Cytotherapy; 2016 Mar; 18(3):452-64. PubMed ID: 26857234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation.
    Trowbridge JJ; Xenocostas A; Moon RT; Bhatia M
    Nat Med; 2006 Jan; 12(1):89-98. PubMed ID: 16341242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the GSK-3β inhibitor (2Z,3E)-6-bromoindirubin-3'-oxime upon ovarian cancer cells.
    Yu AS; Zhao L
    Tumour Biol; 2016 Apr; 37(4):4857-64. PubMed ID: 26526575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of scid repopulating cells.
    Rossmanith T; Schröder B; Bug G; Müller P; Klenner T; Knaus R; Hoelzer D; Ottmann OG
    Stem Cells; 2001; 19(4):313-20. PubMed ID: 11463951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic repopulating ability of CD34⁺ progenitor cells ex vivo expanded with different cytokine combinations.
    Du Z; Jin H; Cai H; Yang S; Tan WS
    Artif Cells Nanomed Biotechnol; 2015; 43(6):398-402. PubMed ID: 24665846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
    Dastjerdi FV; Zeynali B; Tafreshi AP; Shahraz A; Chavoshi MS; Najafabadi IK; Vardanjani MM; Atashi A; Soleimani M
    Cell Biol Int; 2012 Nov; 36(11):967-72. PubMed ID: 22775567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
    Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
    Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The GSK-3 inhibitor BIO promotes proliferation in mammalian cardiomyocytes.
    Tseng AS; Engel FB; Keating MT
    Chem Biol; 2006 Sep; 13(9):957-63. PubMed ID: 16984885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSK-3β inhibitor 6-bromo-indirubin-3'-oxime promotes both adhesive activity and drug resistance in colorectal cancer cells.
    Liu K; Li J; Wu X; Chen M; Luo F; Li J
    Int J Oncol; 2017 Dec; 51(6):1821-1830. PubMed ID: 29039496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of GSK-3beta promotes survival and proliferation of megakaryocytic cells through a beta-catenin-independent pathway.
    Soda M; Willert K; Kaushansky K; Geddis AE
    Cell Signal; 2008 Dec; 20(12):2317-23. PubMed ID: 18804163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis.
    Xingi E; Smirlis D; Myrianthopoulos V; Magiatis P; Grant KM; Meijer L; Mikros E; Skaltsounis AL; Soteriadou K
    Int J Parasitol; 2009 Oct; 39(12):1289-303. PubMed ID: 19445946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of ex vivo expanded and unexpanded cord blood units in immunodeficient mice using insulin growth factor binding protein-2-augmented mesenchymal cell cocultures.
    Ong LM; Fan X; Chu PP; Gay FP; Bari S; Ang JM; Li Z; Chen J; Lim SK; Bunte RM; Hwang WY
    Biol Blood Marrow Transplant; 2012 May; 18(5):674-82. PubMed ID: 22240732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.